Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +16,120 38,873.51
2020-02-09 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −16,120 32,241
2020-02-09 Drape Eric Executive VP Global Operations Option exercise +6,567 23,762
2020-02-09 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −6,567 13,135
2020-02-09 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +13,135 23,729.7
2020-02-09 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −13,135 26,270
2020-02-09 Daniell Richard Exec. VP, European Commercial Option exercise +13,135 14,811
2020-02-09 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −13,135 26,270
2019-12-31 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +4,640 25,212.51
2019-12-31 Fridriksdottir Hafrun Executive VP, Global R&D Sale −2,459 $9.92 $24K 22,753.51
2019-12-31 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −4,640 0
2019-12-02 Fridriksdottir Hafrun Executive VP, Global R&D Sale −4,310 $10.49 $45K 20,572.51
2019-11-30 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +8,133 24,882.51
2019-11-30 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −8,133 0
2019-11-05 McClellan Michael James EVP, Chief Financial Officer Option exercise +695 16,140.27
2019-11-05 McClellan Michael James EVP, Chief Financial Officer Sale −242 $8.83 $2K 15,898.27
2019-11-05 McClellan Michael James EVP, Chief Financial Officer Option exercise · Restricted Share Units −695 0
2019-11-03 Schultz Kare President and CEO Option exercise +63,613 63,613
2019-11-03 Schultz Kare President and CEO Option exercise · Restricted Share Units −63,613 476,389
2019-09-18 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,241 2,629.49

Page 61 of 76 · 1,517 trades